• Manufacturers (D)

Impact Biomedical initiates Quantum, a new frontier in Pharmaceutical Development

New Delhi, August  04, 2020: Impact Biomedical, a wholly-owned subsidiary of SGX-listed Singapore eDevelopment, has announced the initiation of Quantum,…

• Archives

Singapore eDevelopment (SGX:40V) Subsidiary, Global BioLife’s 3F Antimicrobial Fragrance Shows Efficacy against Tuberculosis

Singapore, January 29, 2019: Singapore Exchange-listed Singapore eDevelopment Limited (Stock Code 40V) (“SeD”) wishes to announce today that its U.S.…

Huakang Biomedical Holdings Company Limited Announces the Offer Price and Allotment Results of the Share Offer

Received Positive Response in the Public Offer Hong Kong, December 17, 2018: Huakang Biomedical Holdings Company Limited (“Huakang Biomed” or…